April 24, 2019
Fulcrum seeks FSHD therapy in deal for dropped GSK asset
BioWorld
September 5, 2018
Fulcrum Therapeutics raises $80M to develop muscular dystrophy drug
MedCity News
Fulcrum’s genetic levers
BioCentury
